Episode 8 - David Sullivan on New Modalities, Price, Patients and the Pharma Landscape

The Future of Pharma

Contenu fourni par Samir Gondalia, ISPE Boston, Samir Gondalia, and ISPE Boston. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Samir Gondalia, ISPE Boston, Samir Gondalia, and ISPE Boston ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

4+ y ago 29:28

MP3•Maison d'episode

My guest today is David Sullivan, Sr. Director and Global Lead of Vaccines and Biologics MSAT at Pfizer. He did his Bachelor's in Biotechnology from Worcester Polytechnic Institute and Master's in Engineering Management from Tufts University. Over the years, he's worked in process development, pilot plant, next generation technology, vaccines and biologocs MSAT. I have known Dave for over 15 years and have always been impressed with the width of his knowledge and have never had a boring conversation about anything with him. In this episode, we talk about new modalities, the current changes happening in the pharma industry landscape, the price factor, the patients first philosophy and how that's all going to impact the future of pharma.

Also, check out his book recommendation, "Trillion Dollar Coach" to learn about the leadership lessons from Bill Campbell, a revered executive who was called "Coach" by Steve Jobs, Larry Page, Sergei Brin and Eric Schmidt among others. Here's Dave Sullivan.

27 episodes

#Science #Fitness #Medicine #Samir Gondalia, ISPE Boston #ISPE Boston #Samir Gondalia #Boston #Gondalia #Healthcare #Innovation #Ispeboston #Pharma #Pharmaceutical #ISPE